3.27

2.83% 0.09

After Hours: 3.13 -0.14 -4.28%

Quanterix Corp (QTRX)

Overview News Price History Option Chain Financials Discussions Forecast

Quanterix Corp stock is traded at $3.27, with a volume of 563.46K. It is up +2.83% in the last 24 hours and up +17.20% over the past month. Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Previous Close:

$3.18

Open:

$3.23

24h Volume:

563.46K

Relative Volume:

0.68

Market Cap:

$154.65M

Revenue:

$144.98M

Net Income/Loss:

$-104.19M

P/E Ratio:

-1.3815

EPS:

-2.367

Net Cash Flow:

$-82.90M

1W Performance:

+6.51%

1M Performance:

+17.20%

6M Performance:

-17.42%

1Y Performance:

-37.83%

1-Day Range:

$3.105

$3.29

1-Week Range:

$3.005

$3.29

52-Week Range:

$2.15

$8.77

Quanterix Corp Stock (QTRX) Company Profile

Name

Quanterix Corp

Sector

Healthcare (1067)

Industry

Medical Devices (139)

Phone

617-301-9400

Address

900 MIDDLESEX TURNPIKE, BILLERICA, MA

Employee

450

Twitter

@QuanterixSimoa

Next Earnings Date

2026-11-09

Latest SEC Filings

QTRX's Discussions on Twitter

Compare QTRX vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
QTRX Quanterix Corp	3.27	154.65M	144.98M	-104.19M	-82.90M	-2.367
ABT Abbott Laboratories	101.29	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	88.64	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.36	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.92	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.29	49.74B	6.30B	1.07B	1.09B	1.8406

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold
Feb-01-24	Initiated	Scotiabank	Sector Outperform
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform
May-23-23	Upgrade	Goldman	Neutral → Buy
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-02-22	Upgrade	Goldman	Sell → Neutral
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell

View All

Quanterix Corp Stock (QTRX) Latest News

Sep 25, 2026

Quanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel Development - marketscreener.com

Sep 25, 2026

Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026 - marketscreener.com

Sep 25, 2026

Sep 22, 2026

Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Sep 22, 2026

Sep 18, 2026

Quanterix Corp (NASDAQ: QTRX) Grants 260,315 Derivative Securities to Chief Commercial Officer Gute James Edward Jr. - Kalkine Media

Sep 18, 2026

Sep 17, 2026

Quanterix (QTRX) awards its CCO 260K RSUs - Stock Titan

Sep 17, 2026

Quanterix CTO Michael Francis Executes 1,558 Stock Options and Forfeits 467 Shares on September 15, 2026 - Kalkine Media

Sep 17, 2026

Sep 16, 2026

365,326 stock units go to two new employees at Quanterix. They vest over four years. - Stock Titan

Sep 16, 2026

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Sep 16, 2026

Quanterix (QTRX) CTO converts RSUs, withholds shares for taxes - Stock Titan

Sep 16, 2026

Sep 14, 2026

Quanterix Corporation Announces Appointment of Dr. Yuri Fesko to Chief Medical Officer - marketscreener.com

Sep 14, 2026

Sep 04, 2026

Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.

Sep 04, 2026

Sep 01, 2026

Quanterix (NASDAQ: QTRX) CTO uses shares to cover exercise price or taxes - Stock Titan

Sep 01, 2026

Aug 21, 2026

Bruker Corporation Executive is Named Finance Chief at Quanterix - Medical Product Outsourcing

Aug 21, 2026

Aug 20, 2026

Quanterix (QTRX) director adds 3,955 shares via RSU vest - Stock Titan

Aug 20, 2026

Quest Diagnostics Executive Recruited to Quanterix’s Senior Management Team - Medical Product Outsourcing

Aug 20, 2026

Aug 19, 2026

Quanterix (QTRX) CCO files initial ownership report with no shares - Stock Titan

Aug 19, 2026

Quanterix (QTRX) director now holds 162,401 shares - Stock Titan

Aug 19, 2026

Aug 17, 2026

Quanterix (QTRX) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 17, 2026

QTRX Maintains Rating by Canaccord Genuity -- Price Target Lowered to $3.00 - GuruFocus

Aug 17, 2026

Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group - MarketBeat

Aug 17, 2026

Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com

Aug 17, 2026

GSA Capital Partners LLP Makes New Investment in Quanterix Corporation $QTRX - MarketBeat

Aug 17, 2026

Aug 16, 2026

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com

Aug 16, 2026

Aug 15, 2026